Cargando…

Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types

Background: The most common type of breast cancer is the ductal type (IDC), followed by lobular type (ILC). Surgery is the main therapy for early-stage breast cancer. Adjuvant chemotherapy might be given to those at high risk of recurrence. Recurrence is still possible after mastectomy and chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrianto, Andreas, Sudiana, I Ketut, Suprabawati, Desak Gede Agung, Notobroto, Hari Basuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692586/
https://www.ncbi.nlm.nih.gov/pubmed/38046195
http://dx.doi.org/10.12688/f1000research.134302.2
_version_ 1785152975000305664
author Andrianto, Andreas
Sudiana, I Ketut
Suprabawati, Desak Gede Agung
Notobroto, Hari Basuki
author_facet Andrianto, Andreas
Sudiana, I Ketut
Suprabawati, Desak Gede Agung
Notobroto, Hari Basuki
author_sort Andrianto, Andreas
collection PubMed
description Background: The most common type of breast cancer is the ductal type (IDC), followed by lobular type (ILC). Surgery is the main therapy for early-stage breast cancer. Adjuvant chemotherapy might be given to those at high risk of recurrence. Recurrence is still possible after mastectomy and chemotherapy and most often occurs in the first two years. We aimed to determine the mechanisms in early local recurrence in both types. Methods: We used an observational method with a cross-sectional study design. The samples were patients with early-stage IDC and ILC, who underwent modified radical mastectomy (MRM) and got adjuvant chemotherapy with taxan and anthracycline base, and experienced recurrence in the first two years after surgery. The materials in this study were paraffin blocks from surgical specimens; we examined vimentin, α-SMA and MMP1, PDGF and CD95 by immunohistochemistry (IHC). Data analysis was done using OpenEpi 3.0.1 and EZR. We used pathway analysis with linear regression. Results: There were 25 samples with local recurrence and 25 samples without recurrence in the ductal type group. The lobular type group consisted of six subjects without recurrence and seven with recurrence. There were significant differences in the expression of vimentin (p=0.000 and 0.021, respectively), PDGF (p=0.000 and 0.002) and CD95 (p=0.000 and 0.045) in ductal and lobular cancer types, respectively. MMP1 (p=0.000) and α-SMA (p=0.000) only showed a significant difference in the ductal type. The pathway analysis showed that in the ductal type, the mechanism of recurrence was enabled by two factors: α-SMA and CD95. Meanwhile, for the lobular type, the recurrence mechanism was through the CD95 pathway. Conclusions: Local recurrence in early-stage IDC and ILC had different mechanisms.  These findings are expected to make cancer treatment in both types more focused and efficient.
format Online
Article
Text
id pubmed-10692586
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-106925862023-12-03 Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types Andrianto, Andreas Sudiana, I Ketut Suprabawati, Desak Gede Agung Notobroto, Hari Basuki F1000Res Research Article Background: The most common type of breast cancer is the ductal type (IDC), followed by lobular type (ILC). Surgery is the main therapy for early-stage breast cancer. Adjuvant chemotherapy might be given to those at high risk of recurrence. Recurrence is still possible after mastectomy and chemotherapy and most often occurs in the first two years. We aimed to determine the mechanisms in early local recurrence in both types. Methods: We used an observational method with a cross-sectional study design. The samples were patients with early-stage IDC and ILC, who underwent modified radical mastectomy (MRM) and got adjuvant chemotherapy with taxan and anthracycline base, and experienced recurrence in the first two years after surgery. The materials in this study were paraffin blocks from surgical specimens; we examined vimentin, α-SMA and MMP1, PDGF and CD95 by immunohistochemistry (IHC). Data analysis was done using OpenEpi 3.0.1 and EZR. We used pathway analysis with linear regression. Results: There were 25 samples with local recurrence and 25 samples without recurrence in the ductal type group. The lobular type group consisted of six subjects without recurrence and seven with recurrence. There were significant differences in the expression of vimentin (p=0.000 and 0.021, respectively), PDGF (p=0.000 and 0.002) and CD95 (p=0.000 and 0.045) in ductal and lobular cancer types, respectively. MMP1 (p=0.000) and α-SMA (p=0.000) only showed a significant difference in the ductal type. The pathway analysis showed that in the ductal type, the mechanism of recurrence was enabled by two factors: α-SMA and CD95. Meanwhile, for the lobular type, the recurrence mechanism was through the CD95 pathway. Conclusions: Local recurrence in early-stage IDC and ILC had different mechanisms.  These findings are expected to make cancer treatment in both types more focused and efficient. F1000 Research Limited 2023-09-29 /pmc/articles/PMC10692586/ /pubmed/38046195 http://dx.doi.org/10.12688/f1000research.134302.2 Text en Copyright: © 2023 Andrianto A et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Andrianto, Andreas
Sudiana, I Ketut
Suprabawati, Desak Gede Agung
Notobroto, Hari Basuki
Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
title Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
title_full Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
title_fullStr Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
title_full_unstemmed Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
title_short Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
title_sort immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692586/
https://www.ncbi.nlm.nih.gov/pubmed/38046195
http://dx.doi.org/10.12688/f1000research.134302.2
work_keys_str_mv AT andriantoandreas immunesystemandtumormicroenvironmentinearlystagebreastcancerdifferentmechanismsforearlyrecurrenceaftermastectomyandchemotherapyonductalandlobulartypes
AT sudianaiketut immunesystemandtumormicroenvironmentinearlystagebreastcancerdifferentmechanismsforearlyrecurrenceaftermastectomyandchemotherapyonductalandlobulartypes
AT suprabawatidesakgedeagung immunesystemandtumormicroenvironmentinearlystagebreastcancerdifferentmechanismsforearlyrecurrenceaftermastectomyandchemotherapyonductalandlobulartypes
AT notobrotoharibasuki immunesystemandtumormicroenvironmentinearlystagebreastcancerdifferentmechanismsforearlyrecurrenceaftermastectomyandchemotherapyonductalandlobulartypes